Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Alpha Lipoic Acid
Therapeutic Area : Neurology
Study Phase : Phase II
Sponsor : BREGO Life Sciences
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Alpha-lipoic acid is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Diabetic Neuropathies.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
August 23, 2024
Lead Product(s) : Alpha Lipoic Acid
Therapeutic Area : Neurology
Highest Development Status : Phase II
Sponsor : BREGO Life Sciences
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Alpha Lipoic Acid
Therapeutic Area : Nephrology
Study Phase : Phase III
Sponsor : Eva Pharma
Deal Size : Inapplicable
Deal Type : Inapplicable
Alpha Lipoic Acid in Pediatrics on Hemodialysis
Details : Alpha-lipoic acid is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Kidney Diseases.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
February 29, 2024
Lead Product(s) : Alpha Lipoic Acid
Therapeutic Area : Nephrology
Highest Development Status : Phase III
Sponsor : Eva Pharma
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Alpha Lipoic Acid
Therapeutic Area : Neurology
Study Phase : Phase IV
Sponsor : MARC-CRO
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Alpha-lipoic acid is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Diabetic Neuropathies.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
April 14, 2023
Lead Product(s) : Alpha Lipoic Acid
Therapeutic Area : Neurology
Highest Development Status : Phase IV
Sponsor : MARC-CRO
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Alpha Lipoic Acid
Therapeutic Area : Nutrition and Weight Loss
Study Phase : Undisclosed
Sponsor : Institut Polyclinique de Cannes (IPOCA)
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Alpha Lipoic Acid is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of Obesity.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
June 18, 2020
Lead Product(s) : Alpha Lipoic Acid
Therapeutic Area : Nutrition and Weight Loss
Highest Development Status : Undisclosed
Sponsor : Institut Polyclinique de Cannes (IPOCA)
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Alpha Lipoic Acid
Therapeutic Area : Neurology
Study Phase : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Alpha-lipoic acid is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Diabetic Neuropathies.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
January 02, 2020
Lead Product(s) : Alpha Lipoic Acid
Therapeutic Area : Neurology
Highest Development Status : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Alpha Lipoic Acid
Therapeutic Area : Endocrinology
Study Phase : Phase II/ Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Lipoic Acid is a Other Small Molecule drug candidate, which is currently being evaluated in phase II/ phase III clinical studies for the treatment of Diabetes Mellitus.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
October 20, 2010
Lead Product(s) : Alpha Lipoic Acid
Therapeutic Area : Endocrinology
Highest Development Status : Phase II/ Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable